X0306 4 2016-02-26 0 0000033488 ESCALADE INC ESCA 0001660416 Fetherman David L. 817 MAXWELL AVENUE EVANSVILLE IN 47711 1 1 0 0 CEO and President Common Stock 2016-02-27 4 M 0 3000 A 103054 D Restricted Stock Units 2016-02-27 4 M 0 3000 0 D Common Stock 3000 6000 D Restricted Stock Units 2016-02-26 4 A 0 6800 0 A Common Stock 6800 6800 D Stock Options 14.39 2016-02-26 4 A 0 20000 0 A 2022-02-26 Common Stock 20000 20000 D Restricted Stock Units (RSUs) converted into common stock on a one-for-one basis. On February 27, 2014, the reporting person was granted 9,000 RSUs which vested one third on February 27, 2018, and were settled in shares of common stock as reported in Table I of this Form 4. The remaining 6,000 RSUs will vest one half on February 27, 2017 and one half on February 27, 2018 provided the reporting person remains employed by the company as of such date. The vesting of these RSUs also were subject to the company's common stock achieving certain market performance tests established by the Compensation Committee of the company's Board of Directors, which tests were satisfied. Each RSU represents a right to receive one share of ESCA common stock granted pursuant to the Escalade, Incorporated 2007 Incentive Plan. On February 26, 2016, the reporting person was granted 6,800 RSUs which will vest one third on each of February 26, 2018, February 26, 2019, and February 26, 2020 provided that the reporting person is still employed by the company as of such dated and the company's common stock has achieved certain market performance tests. The market performance tests have been established by the Compensation Committee of the company's Board of Directors. Vested shares will be delivered to the reporting person at such time unless the reporting person has deferred receipt. Each stock option represents a right to purchase at the exercise price one share of ESCA common stock granted under the Escalade, Incorporated 2007 Incentive Plan. On February 26, 2016, the reporting person was granted 20,000 stock options, which will vest one third on each of February 26, 2019, February 26, 2020, and February 26, 2021, provided that the reporting person is still employed by the company as of such date. The exercise price was set by the Compensation Committee of the company's Board of Directors at a price 15% higher than the closing price of a share of ESCA common stock on the grant date. /s/David L. Fetherman 2016-03-01